TFO Wealth Partners’s Pediatrix Medical MD Stock Holding History

TFO Wealth Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12	Closed	-$171	–	1029
2023 Q3	$171	Buy	+12	New	+$165	﹤0.01%	875

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TFO Wealth Partners's MD Position: Q4 2023 in Review

TFO Wealth Partners sold out of Pediatrix Medical (MD) in Q4 2023, closing a stake of 12 shares — an estimated $171 sold.

TFO Wealth Partners first reported a position in MD in Q3 2023 and held it in 1 quarter. The position peaked at $171 in Q3 2023. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.

TFO Wealth Partners reported no remaining Pediatrix Medical position as of Q4 2023 after selling out during the quarter.
TFO Wealth Partners sold 12 Pediatrix Medical shares in Q4 2023, an estimated $171.
TFO Wealth Partners first reported a position in Pediatrix Medical in Q3 2023 and held it in 1 quarter.
TFO Wealth Partners's Pediatrix Medical position peaked at $171 in Q3 2023.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.